EGFR and esophageal adenocarcinoma: Overexpression of the hepatocyte growth factor receptor (CMET) has also been correlated with poor prognosis in esophageal adenocarcinoma, and inhibition of CMET-dependent signaling regulates the activity of HER1 and HER3 [9].